Financial Statements — CBIO
Balance Sheet
(in millions USD)| Metric | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 189.16 | 133.26 | 152.75 | 5.61 | 14.39 | 22.39 | 31.28 | 49.41 | 58.04 | 65.00 | 51.62 | 60.24 | 76.52 | 101.92 | 118.85 | 132.47 |
| Accounts Receivable | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Current Assets | 195.56 | 134.56 | 154.23 | 5.99 | 15.65 | 23.86 | 33.27 | 52.01 | 60.37 | 68.09 | 53.85 | 61.26 | 77.46 | 104.13 | 120.31 | 133.71 |
| Property, Plant & Equipment | 0.93 | 0.78 | 0.19 | -- | -- | -- | -- | 0.13 | 0.17 | 0.20 | 0.29 | 0.33 | 0.35 | 0.43 | 0.49 | 0.55 |
| Total Non-current Assets* | 3.57 | 3.71 | 3.21 | 0.00 | 0.05 | 0.56 | 0.94 | 1.19 | 1.45 | 0.84 | 2.11 | 3.78 | 4.00 | 3.81 | 4.06 | 4.31 |
| Total Assets | 199.13 | 138.27 | 157.43 | 5.99 | 15.70 | 24.42 | 34.20 | 53.20 | 61.82 | 68.92 | 55.96 | 65.04 | 81.46 | 107.94 | 124.38 | 138.02 |
| Accounts Payable | -- | -- | -- | 0.10 | 0.58 | 0.95 | 0.76 | 0.33 | 0.24 | 0.48 | 0.85 | 1.27 | 2.28 | 1.39 | 1.17 | 2.14 |
| Total Current Liabilities | 14.19 | 20.30 | 16.75 | 2.62 | 4.32 | 4.36 | 5.29 | 6.39 | 6.57 | 6.74 | 7.75 | 8.94 | 12.78 | 9.66 | 10.25 | 10.84 |
| Total Non-current Liabilities* | 1.09 | 1.32 | 1.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.26 | 0.45 | 0.00 | 0.10 | 0.38 | 0.65 | 1.72 | 1.84 | 2.05 |
| Total Liabilities | 15.28 | 21.63 | 18.18 | 2.62 | 4.32 | 4.36 | 5.29 | 6.65 | 7.02 | 6.74 | 7.84 | 9.32 | 13.43 | 11.38 | 12.09 | 12.90 |
| Retained Earnings | (195.09) | (79.41) | (54.80) | (496.71) | (487.14) | (477.32) | (467.22) | (447.41) | (438.20) | (429.95) | (409.34) | (400.82) | (387.55) | (355.48) | (338.14) | (323.74) |
| Total Stockholder Equity | 183.85 | 116.64 | 139.25 | 3.38 | 11.38 | 20.06 | 28.91 | 46.55 | 54.80 | 62.18 | 48.12 | 55.73 | 68.03 | 96.57 | 112.29 | 125.12 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1.04 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | 0.00 | 0.08 | -- | 0.02 | 0.09 | 0.00 |
| Research & Development | 17.90 | 105.64 | 20.35 | 12.08 | 0.01 | 0.23 | 1.72 | 6.29 | 6.03 | 5.29 | 5.29 | 4.07 | 5.42 | 5.89 | 4.92 | 7.97 | 9.60 | 12.90 | 13.28 | 10.17 |
| Selling, General & Admin | 7.87 | 8.52 | 5.54 | 8.95 | 2.38 | 5.08 | 4.01 | 4.07 | 5.09 | 4.31 | 4.52 | 4.86 | 5.52 | 4.73 | 3.84 | 5.45 | 5.06 | 4.55 | 4.14 | 4.24 |
| Total Operating Expenses | 25.77 | 114.16 | 25.89 | 21.03 | 2.40 | 7.33 | 11.23 | 10.36 | 11.12 | 9.60 | 9.81 | 8.93 | 10.94 | 10.62 | 8.77 | 13.43 | 14.66 | 17.44 | 17.42 | 14.40 |
| Operating Income | (24.73) | (103.32) | (25.88) | (21.03) | (2.40) | (7.33) | (11.23) | (10.36) | (11.12) | (9.59) | (9.81) | (8.93) | (10.94) | (10.62) | (8.77) | (13.35) | (14.66) | (17.43) | (17.34) | (14.40) |
| Pretax Income* | (23.28) | -- | (24.61) | (21.79) | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Tax Provision | 0.00 | 2.00 | 0.00 | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Income | (23.28) | -- | (24.61) | (21.79) | (2.34) | (7.22) | (9.82) | (10.10) | (10.74) | (9.08) | (9.20) | (8.26) | (10.36) | (10.24) | (8.52) | (13.27) | (14.65) | (17.42) | (17.33) | (14.40) |
| Basic EPS | -- | -- | -- | -- | (0.04) | (0.11) | (0.15) | (0.16) | (0.17) | (0.14) | (0.14) | (0.13) | (0.17) | (0.20) | (0.16) | (0.25) | (0.28) | (0.33) | -- | -- |
| Diluted EPS | -- | -- | -- | -- | -- | (0.11) | (0.15) | (0.16) | (0.17) | (0.14) | (0.14) | (0.13) | (0.17) | (0.20) | (0.16) | (0.25) | (0.28) | (0.33) | -- | -- |
* Derived from reported values
Cash Flow Statement
(in millions USD)| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | (8.94) | (26.74) | (17.54) | (22.15) | (5.11) | (3.70) | (7.99) | (8.89) | (10.51) | (7.61) | (8.68) | (6.97) | (11.61) | (7.91) | (8.62) | (16.23) | (13.70) | (12.81) | (16.95) | (13.61) |
| Capital Expenditures | 0.15 | 0.19 | 0.59 | 0.14 | -- | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.04 | 0.04 | 0.00 | 0.00 | 0.01 |
| Free Cash Flow* | (9.08) | (26.93) | (18.12) | (22.29) | -- | (3.70) | (7.99) | (8.90) | (10.52) | (7.62) | (8.69) | (6.99) | (11.61) | (7.91) | (8.62) | (16.27) | (13.74) | (12.81) | (16.95) | (13.62) |
| Investing Cash Flow | (8.15) | (72.19) | (0.59) | (0.14) | -- | 0.03 | 0.00 | -0.00 | (0.01) | -0.00 | (0.01) | (0.01) | -0.00 | -0.00 | -0.00 | (0.04) | (0.04) | -0.00 | -0.00 | (0.01) |
| Financing Cash Flow | (6.94) | 178.86 | (1.25) | 145.38 | -- | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.02 | 28.74 | -- | -- | -- | -- | 1.14 | 0.02 | 0.00 |
* Derived from reported values